Proteomic and Functional Signatures of Phenoconversion in Presymptomatic Amyotrophic Lateral Sclerosis.
ALS exhibits a measurable molecular prodrome detectable in blood years before diagnosis, and integrated proteomic and genetic profiling may support early identification and trial enrichment strategies.